• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对西巴·科宁ACS:180睾酮检测法进行评估。

Ciba Corning ACS:180 testosterone assay evaluated.

作者信息

Wheeler M J, D'Souza A, Matadeen J, Croos P

机构信息

Department of Chemical Pathology, St. Thomas' Hospital, London, UK.

出版信息

Clin Chem. 1996 Sep;42(9):1445-9.

PMID:8787702
Abstract

A fully automated direct assay of testosterone has been developed for the Ciba Corning ACS:180 immunoassay system. We have evaluated this method and compared specimen results with those from the Diagnostic Products Corp. (DPC) and Medgenix direct assays and an in-house extraction assay. Accuracy of the method was assessed by measuring GC-MS-targeted serum pools. Within-assay im- precision was <6% and between-assay imprecision <9% over the concentration range examined. High concentrations of lipid caused an increase in the measured testosterone but other potential interferents were without effect. Recovery was quantitative but was affected by sex-hormone-binding globulin. The method was positively biased with respect to the DPC and Medgenix assays but negatively biased with the extraction assay. Measurement of the GC-MS-targeted serum pools showed the assay to overestimate recovery by approximately 13%. The ACS:180 assay is particularly attractive as a routine assay because it is fully automated, obtains the first result in only 15 min, and shows good assay performance.

摘要

已为Ciba Corning ACS:180免疫分析系统开发了一种全自动直接检测睾酮的方法。我们对该方法进行了评估,并将样本结果与诊断产品公司(DPC)、Medgenix直接检测法以及一种内部提取检测法的结果进行了比较。通过测量气相色谱-质谱靶向血清池评估了该方法的准确性。在所检测的浓度范围内,批内不精密度<6%,批间不精密度<9%。高浓度脂质会导致测得的睾酮增加,但其他潜在干扰物则无影响。回收率是定量的,但受性激素结合球蛋白的影响。该方法相对于DPC和Medgenix检测法呈正偏差,但相对于提取检测法呈负偏差。对气相色谱-质谱靶向血清池的测量表明,该检测法高估回收率约13%。ACS:180检测法作为一种常规检测法特别有吸引力,因为它是全自动的,仅需15分钟就能获得首个结果,并且检测性能良好。

相似文献

1
Ciba Corning ACS:180 testosterone assay evaluated.对西巴·科宁ACS:180睾酮检测法进行评估。
Clin Chem. 1996 Sep;42(9):1445-9.
2
Serum total testosterone: immunoassay compared with negative chemical ionization gas chromatography-mass spectrometry.血清总睾酮:免疫测定法与负化学电离气相色谱-质谱分析法的比较
Clin Chem. 1996 May;42(5):749-55.
3
A new modular chemiluminescence immunoassay analyser evaluated.一种新型模块化化学发光免疫分析分析仪的评估。
Clin Chem Lab Med. 2000 Mar;38(3):251-60. doi: 10.1515/CCLM.2000.037.
4
Evaluation of automated sex hormone binding globulin immunoassays.
Clin Biochem. 2006 Jan;39(1):91-4. doi: 10.1016/j.clinbiochem.2005.10.012. Epub 2005 Dec 2.
5
Ciba Corning ACS:180 direct total testosterone assay can be used on female sera.西巴·科宁ACS:180直接总睾酮测定法可用于女性血清检测。
Clin Chem. 1997 Aug;43(8 Pt 1):1466-8.
6
Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay.一种新型自动化电化学发光性激素结合球蛋白(SHBG)免疫测定法的评估。
Clin Chem Lab Med. 2005;43(1):86-9. doi: 10.1515/CCLM.2005.013.
7
Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.放射免疫分析法(RIA)和质谱分析法检测男性血清性激素的重现性
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):1004-8. doi: 10.1158/1055-9965.EPI-06-0792.
8
Cross-method comparison of serum androstenedione measurement with respect to the validation of a new fully automated chemiluminescence immunoassay.关于一种新型全自动化学发光免疫测定法验证的血清雄烯二酮测量的跨方法比较。
Clin Biochem. 2018 Dec;62:32-38. doi: 10.1016/j.clinbiochem.2018.09.009. Epub 2018 Sep 24.
9
Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men.采用平台免疫测定法和质谱法检测 3174 名欧洲男性的血清睾酮和雌二醇水平比较;与老年男性诊断的相关性。
Eur J Endocrinol. 2012 Jun;166(6):983-91. doi: 10.1530/EJE-11-1051. Epub 2012 Mar 15.
10
[The importance of methodology in serum testosterone measurement: comparison between a direct immunoassay and a method based on high performance liquid chromatography and tandem mass spectrometry (HPLC/MS-MS)].
Arq Bras Endocrinol Metabol. 2008 Aug;52(6):1050-5. doi: 10.1590/s0004-27302008000600017.

引用本文的文献

1
Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review.评估药物去势疗效的方法:一项系统评价
Cancers (Basel). 2023 Jul 3;15(13):3479. doi: 10.3390/cancers15133479.
2
Definition of Castrate Resistant Prostate Cancer: New Insights.去势抵抗性前列腺癌的定义:新见解
Biomedicines. 2022 Mar 17;10(3):689. doi: 10.3390/biomedicines10030689.
3
Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer.去势睾酮水平对中高危前列腺癌患者的预后意义
World J Clin Oncol. 2019 Aug 24;10(8):283-292. doi: 10.5306/wjco.v10.i8.283.
4
Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide.三种不同的促黄体生成素释放激素激动剂在前列腺癌患者去势治疗中的疗效比较:戈舍瑞林、曲普瑞林与亮丙瑞林。
Investig Clin Urol. 2019 Jul;60(4):244-250. doi: 10.4111/icu.2019.60.4.244. Epub 2019 May 21.
5
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement.睾酮抑制在复发性或转移性前列腺癌治疗中的应用——一份加拿大共识声明
Can Urol Assoc J. 2018 Feb;12(2):30-37. doi: 10.5489/cuaj.5116. Epub 2017 Dec 19.
6
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.最大程度睾酮抑制在复发性和转移性前列腺癌治疗中的应用
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):16-23. doi: 10.5489/cuaj.4303.
7
Efficacy of switching therapy of luteinizing hormone-releasing hormone analogue for advanced prostate cancer.促黄体生成素释放激素类似物转换疗法治疗晚期前列腺癌的疗效
Kaohsiung J Med Sci. 2016 Nov;32(11):567-571. doi: 10.1016/j.kjms.2016.09.005. Epub 2016 Nov 4.
8
Comparison of the Efficacy of Two Brands of Triptorelin (Microrelin and Diphereline) in Reducing Prostate-Specific Antigen and Serum Testosterone in Prostate Cancer: A Double-Blinded Randomized Clinical Trial.两种曲普瑞林品牌(米卡雷林和达菲林)在降低前列腺癌患者前列腺特异性抗原和血清睾酮水平方面的疗效比较:一项双盲随机临床试验
Nephrourol Mon. 2015 May 25;7(3):e27107. doi: 10.5812/numonthly.7(3)2015.27107. eCollection 2015 May.
9
Defining a new testosterone threshold for medical castration: Results from a prospective cohort series.确定医学去势的新睾酮阈值:一项前瞻性队列研究系列的结果
Can Urol Assoc J. 2013 May-Jun;7(5-6):E263-7. doi: 10.5489/cuaj.471.
10
LHRH Agonists for the Treatment of Prostate Cancer: 2012.用于治疗前列腺癌的促黄体激素释放激素激动剂:2012年。
Rev Urol. 2012;14(1-2):1-12.